365 Health Care

UNC Science Short: CRISPR/Cas9 to treat Angelman Syndrome



Mark Zylka, PhD, director of the UNC Neuroscience Center, is using CRISPR/Cas9 technology to determine if the gene editing …

source

Share this post

Search
Facebook
Twitter
LinkedIn
Pinterest

Recent Posts

Newsletter

Subscribe for our monthly newsletter to stay updated

Gallery

Suspendisse dictum tristique dolor

Donec vitae libero nec elit vulputate cursus a eu metus. Quisque non ex at nibh dictum tincidunt. Vivamus lacinia in velit a tincidunt.